BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34385275)

  • 1.
    Succony L; Gómez-López S; Pennycuick A; Alhendi ASN; Davies D; Clarke SE; Gowers KHC; Wright NA; Jensen KB; Janes SM
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34385275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development.
    Lu L; Teixeira VH; Yuan Z; Graham TA; Endesfelder D; Kolluri K; Al-Juffali N; Hamilton N; Nicholson AG; Falzon M; Kschischo M; Swanton C; Wright NA; Carroll B; Watt FM; George JP; Jensen KB; Giangreco A; Janes SM
    J Pathol; 2013 Mar; 229(4):608-20. PubMed ID: 23208928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC Protects against Carcinogen-Induced Histologic Progression to Lung Squamous Cell Carcinoma by Reduced Basal Epithelial Cell Proliferation.
    Sears CR; Zhou H; Hulsey E; Aidoo BA; Sandusky GE; Al Nasrallah N
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRIG and cancer prognosis.
    Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
    Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model.
    Dwyer-Nield LD; McArthur DG; Hudish TM; Hudish LI; Mirita C; Sompel K; Smith AJ; Alavi K; Ghosh M; Merrick DT; Tennis MA; Keith RL
    Int J Cancer; 2022 Dec; 151(12):2195-2205. PubMed ID: 35830207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRIG1 as a potential novel marker for neoplastic transformation in ocular surface squamous neoplasia.
    Nagata M; Nakamura T; Sotozono C; Inatomi T; Yokoi N; Kinoshita S
    PLoS One; 2014; 9(4):e93164. PubMed ID: 24709893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.
    Torigoe H; Yamamoto H; Sakaguchi M; Youyi C; Namba K; Sato H; Shien K; Soh J; Suzawa K; Tomida S; Tsukuda K; Miyoshi S; Toyooka S
    Carcinogenesis; 2018 May; 39(5):719-727. PubMed ID: 29546323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of LRIG1, a Negative Regulator of EGFR, Is Dynamically Altered during Different Stages of Gastric Carcinogenesis.
    Yu S; Yang M; Lim KM; Cho Y; Kim H; Lee K; Jeong SH; Coffey RJ; Goldenring JR; Nam KT
    Am J Pathol; 2018 Dec; 188(12):2912-2923. PubMed ID: 30248341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma.
    Valencia K; Sainz C; Bértolo C; de Biurrun G; Agorreta J; Azpilikueta A; Larrayoz M; Bosco G; Zandueta C; Redrado M; Redín E; Exposito F; Serrano D; Echepare M; Ajona D; Melero I; Pio R; Thomas R; Calvo A; Montuenga LM
    Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 34870316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
    Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
    Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lrig1 expression identifies quiescent stem cells in the ventricular-subventricular zone from postnatal development to adulthood and limits their persistent hyperproliferation.
    Nam HS; Capecchi MR
    Neural Dev; 2023 Jan; 18(1):1. PubMed ID: 36631891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer.
    Ghosh M; Dwyer-Nield LD; Kwon JB; Barthel L; Janssen WJ; Merrick DT; Keith RL
    PLoS One; 2015; 10(4):e0122823. PubMed ID: 25860262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is downregulated in Invasive ductal carcinoma and potential prognostic marker of breast cancer.
    Piracha ZZ; Saeed U
    J Cancer Res Ther; 2023 Oct; 19(7):1870-1879. PubMed ID: 38376291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway brushing as a new experimental methodology to detect airway gene expression signatures in mouse lung squamous cell carcinoma.
    Pan J; Xiong D; Zhang Q; Szabo E; Miller MS; Lubet RA; Wang Y; You M
    Sci Rep; 2018 Jun; 8(1):8895. PubMed ID: 29891994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
    Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
    Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-rich repeats and immunoglobulin-like domains protein 1 and fascin actin-bundling protein 1 expression in nonsmall cell lung cancer.
    Zhang J; Wang X; Zhang Y; Wu J; Zhou N
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C248-C251. PubMed ID: 28230028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.
    Wang Y; Poulin EJ; Coffey RJ
    Br J Cancer; 2013 May; 108(9):1765-70. PubMed ID: 23558895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant epithelial polarity cues drive the development of precancerous airway lesions.
    Tilston-Lunel A; Mazzilli S; Kingston NM; Szymaniak AD; Hicks-Berthet J; Kern JG; Abo K; Reid ME; Perdomo C; Wilson AA; Spira A; Beane J; Varelas X
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells.
    Yokdang N; Hatakeyama J; Wald JH; Simion C; Tellez JD; Chang DZ; Swamynathan MM; Chen M; Murphy WJ; Carraway Iii KL; Sweeney C
    Oncogene; 2016 Jun; 35(22):2932-47. PubMed ID: 26387542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer.
    Lindquist D; Alsina FC; Herdenberg C; Larsson C; Höppener J; Wang N; Paratcha G; Tarján M; Tot T; Henriksson R; Hedman H
    Int J Oncol; 2018 Apr; 52(4):1189-1197. PubMed ID: 29436694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.